Beckman Coulter Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Beckman Coulter Inc.
With many medtechs restructuring for core growth in the post-pandemic era, Abbott relied on organic growth in 2022 to move to the top of the global medtech ranking. The strength of the US dollar was not kind to companies reporting in local currencies on converting revenues to dollars.
Becton Dickinson claims Beckman Coulter has been knowingly violating several patents since at least 2015.
The FDA has granted an emergency use authorization for a COVID-19 IgM antibody blood test that runs on Abbott’s Architect and Alinity platforms.
The company expects testing for IgM antibodies will be useful in areas where PCR testing is not keeping up with demand.
- Research, Analytical Equipment & Supplies
In Vitro Diagnostics
- Chemistry, Immunoassay
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.